Anxiety, depression, and quality of life in children and adults with alopecia areata: A systematic review and meta-analysis
Alopecia areata (AA) is a non-scarring hair loss condition, subclassified into AA, alopecia universalis, and alopecia totalis. There are indications that people with AA experience adverse psychosocial outcomes, but previous studies have not included a thorough meta-analysis and did not compare peopl...
Saved in:
Published in: | Frontiers in medicine Vol. 9; p. 1054898 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
29-11-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Alopecia areata (AA) is a non-scarring hair loss condition, subclassified into AA, alopecia universalis, and alopecia totalis. There are indications that people with AA experience adverse psychosocial outcomes, but previous studies have not included a thorough meta-analysis and did not compare people with AA to people with other dermatological diagnoses. Therefore, the aim of this systematic review and meta-analysis was to update and expand previous systematic reviews, as well as describing and quantifying levels of anxiety, depression, and quality of life (QoL) in children and adults with AA.
A search was conducted, yielding 1,249 unique records of which 93 were included.
Review results showed that people with AA have higher chances of being diagnosed with anxiety and/or depression and experience impaired QoL. Their psychosocial outcomes are often similar to other people with a dermatological condition. Meta-analytic results showed significantly more symptoms of anxiety and depression in adults with AA compared to healthy controls. Results also showed a moderate impact on QoL. These results further highlight that AA, despite causing little physical impairments, can have a significant amount on patients' well-being.
Future studies should examine the influence of disease severity, disease duration, remission and relapse, and medication use to shed light on at-risk groups in need of referral to psychological care.
[https://www.crd.york.ac.uk/prospero/], identifier [CRD42022323174]. |
---|---|
Bibliography: | content type line 23 SourceType-Scholarly Journals-1 Reviewed by: Alina Constantin, British Association of Dermatologists, United Kingdom; Andrew Messenger, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom This article was submitted to Dermatology, a section of the journal Frontiers in Medicine Edited by: Andrew Robert Thompson, Cardiff and Vale University Health Board, United Kingdom |
ISSN: | 2296-858X 2296-858X |
DOI: | 10.3389/fmed.2022.1054898 |